| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |